001     277922
005     20240229155028.0
024 7 _ |a 10.1093/neuonc/noad124
|2 doi
024 7 _ |a pmid:37534924
|2 pmid
024 7 _ |a 1522-8517
|2 ISSN
024 7 _ |a 1523-5866
|2 ISSN
024 7 _ |a altmetric:152339602
|2 altmetric
037 _ _ |a DKFZ-2023-01578
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Okonechnikov, Konstantin
|0 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110
|b 0
|e First author
|u dkfz
245 _ _ |a Mapping pediatric brain tumors to their origins in the developing cerebellum.
260 _ _ |a Oxford
|c 2023
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1698319194_31146
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a DKFZ-ZMBH Alliance / #EA:B062#EA:B430#LA:B062#LA:B430# / 2023 Oct 3;25(10):1895-1909
520 _ _ |a Distinguishing the cellular origins of childhood brain tumors is key for understanding tumor initiation and identifying lineage-restricted, tumor-specific therapeutic targets. Previous strategies to map the cell-of-origin typically involved comparing human tumors to murine embryonal tissues, which is potentially limited due to species-specific differences. The aim of this study was to unravel the cellular origins of the three most common pediatric brain tumors, ependymoma, pilocytic astrocytoma, and medulloblastoma, using a developing human cerebellar atlas.We used a single-nucleus atlas of the normal developing human cerebellum consisting of 176,645 cells as a reference for an in-depth comparison to 4,416 bulk and single-cell transcriptome tumor datasets, using gene set variation analysis, correlation, and single-cell matching techniques.We find that the astroglial cerebellar lineage is potentially the origin for posterior fossa ependymomas. We propose that infratentorial pilocytic astrocytomas originate from the oligodendrocyte lineage and MHC II genes are specifically enriched in these tumors. We confirm that SHH and Group 3/4 medulloblastomas originate from the granule cell and unipolar brush cell lineages. Radiation-induced gliomas stem from cerebellar glial lineages and demonstrate distinct origins from the primary medulloblastoma. We identify tumor genes that are expressed in the cerebellar lineage of origin, and genes that are tumor specific; both gene sets represent promising therapeutic targets for future study.Based on our results, individual cells within a tumor may resemble different cell types along a restricted developmental lineage. Therefore, we suggest that tumors can arise from multiple cellular states along the cerebellar 'lineage of origin'.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a cerebellum
|2 Other
650 _ 7 |a ependymoma
|2 Other
650 _ 7 |a medulloblastoma
|2 Other
650 _ 7 |a pilocytic astrocytoma
|2 Other
650 _ 7 |a radiation-induced glioma
|2 Other
650 _ 7 |a tumor origin
|2 Other
700 1 _ |a Joshi, Piyush Kumar
|0 P:(DE-He78)ee036c22158d4b18f5228616af640355
|b 1
|e First author
|u dkfz
700 1 _ |a Sepp, Mari
|b 2
700 1 _ |a Leiss, Kevin
|b 3
700 1 _ |a Sarropoulos, Ioannis
|b 4
700 1 _ |a Murat, Florent
|b 5
700 1 _ |a Sill, Martin
|0 P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b
|b 6
|u dkfz
700 1 _ |a Beck, Pengbo
|0 P:(DE-He78)b8f2b74d0482aed61472c7065dc1ed56
|b 7
|u dkfz
700 1 _ |a Chan, Kenneth Chun-Ho
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Korshunov, Andrey
|0 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
|b 9
|u dkfz
700 1 _ |a Sahm, Felix
|0 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
|b 10
|u dkfz
700 1 _ |a Deng, Maximilian Yuanzhe
|0 P:(DE-He78)ce7d0cd1f5edc5c0e08c39b3fdd7b410
|b 11
700 1 _ |a Sturm, Dominik
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 12
|u dkfz
700 1 _ |a DeSisto, John
|b 13
700 1 _ |a Donson, Andrew M
|b 14
700 1 _ |a Foreman, Nicholas K
|b 15
700 1 _ |a Green, Adam L
|0 0000-0002-4469-2358
|b 16
700 1 _ |a Robinson, Giles
|b 17
700 1 _ |a Orr, Brent A
|b 18
700 1 _ |a Gao, Qingsong
|b 19
700 1 _ |a Darrow, Emily
|b 20
700 1 _ |a Hadley, Jennifer L
|b 21
700 1 _ |a Northcott, Paul A
|b 22
700 1 _ |a Gojo, Johannes
|0 P:(DE-He78)a975a4d7d3d59cc6ecc829e98bfe0c15
|b 23
|u dkfz
700 1 _ |a Kawauchi, Daisuke
|b 24
700 1 _ |a Hovestadt, Volker
|b 25
700 1 _ |a Filbin, Mariella G
|b 26
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 27
|u dkfz
700 1 _ |a Zuckermann, Marc
|0 P:(DE-He78)2a8fbc2efe7e5e468472d57f724fe39b
|b 28
|u dkfz
700 1 _ |a Pajtler, Kristian
|0 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
|b 29
|u dkfz
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 30
|u dkfz
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 31
|u dkfz
700 1 _ |a Jäger, Natalie
|0 P:(DE-He78)bff9e3e3d86865d2b0836bb8f3ce98f3
|b 32
|u dkfz
700 1 _ |a Kutscher, Lena
|0 P:(DE-He78)a56d7a8e916d458441b5ac9484d73c5d
|b 33
|e Last author
|u dkfz
700 1 _ |a Kaessmann, Henrik
|b 34
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 35
|e Last author
|u dkfz
773 _ _ |a 10.1093/neuonc/noad124
|g p. noad124
|0 PERI:(DE-600)2094060-9
|n 10
|p 1895-1909
|t Neuro-Oncology
|v 25
|y 2023
|x 1522-8517
909 C O |p VDB
|o oai:inrepo02.dkfz.de:277922
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)ee036c22158d4b18f5228616af640355
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)b8f2b74d0482aed61472c7065dc1ed56
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)ce7d0cd1f5edc5c0e08c39b3fdd7b410
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)a975a4d7d3d59cc6ecc829e98bfe0c15
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)2a8fbc2efe7e5e468472d57f724fe39b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)551bb92841f634070997aa168d818492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)bff9e3e3d86865d2b0836bb8f3ce98f3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)a56d7a8e916d458441b5ac9484d73c5d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2023
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-08
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURO-ONCOLOGY : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NEURO-ONCOLOGY : 2022
|d 2023-10-24
920 2 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 2 _ |0 I:(DE-He78)B430-20160331
|k B430
|l Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen
|x 1
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)B430-20160331
|k B430
|l Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen
|x 2
920 1 _ |0 I:(DE-He78)B300-20160331
|k B300
|l KKE Neuropathologie
|x 3
920 1 _ |0 I:(DE-He78)B360-20160331
|k B360
|l Pädiatische Gliomforschung
|x 4
920 0 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 0 _ |0 I:(DE-He78)B430-20160331
|k B430
|l Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)B430-20160331
980 _ _ |a I:(DE-He78)B300-20160331
980 _ _ |a I:(DE-He78)B360-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21